biotech
Care packaging: Inside the Falsified Medicines Directive
April 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, packaging, pharma, pharmaceutical
When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …
Sanofi looks to trim down with divestments
April 16, 2018Sales and Marketing Charterhouse Capital, Sanofi, Zentiva, biotech, drugs, pharma, pharmaceutical
Sanofi has begun part of a larger process of slimming down its business with the sales of 12 medicines. It …
J&J’s ketamine nasal spray for depression continues to impress
April 16, 2018Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical
New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal
April 16, 2018Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …
Evolutionary path of kidney cancer tracked, “born to be bad” type discovered
April 13, 2018Medical Communications, Research and Development Kidney cancer, biotech, drugs, pharma, pharmaceutical
A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …
Roche’s immunotherapy lucky streak ends with deaths in trial
April 13, 2018Medical Communications, Research and Development Exelixis, Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …
EMA announces second-ever public hearing on high-use antibiotics
April 12, 2018Medical Communications Antibiotics, EMA, biotech, drugs, pharma, pharmaceutical
The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding …
Alzheimer’s protein treatment that works in human cells
April 12, 2018Research and Development Alzheimer's disease, Gladstone Institutes, biotech, drugs, pharma, pharmaceutical
One of the major stumbling blocks that science has come up against, when trying to develop potential treatments for Alzheimer’s …
Bayer contraceptive implant public backlash brings results
April 12, 2018Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical
Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …
Sobi receives expanded EU approval for Kineret
April 11, 2018Research and Development, Sales and Marketing Kineret, anti-inflammatory, biotech, drugs, pharma, pharmaceutical, sobi
Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval …
Alexion $855m portfolio boost after Wilson Therapeutics buyout
April 11, 2018Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical
Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …
Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment
April 11, 2018Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …
May announces £75m prostate cancer boost
April 10, 2018Manufacturing and Production, Medical Communications Prostate Cancer UK, UK, biotech, drugs, pharma, pharmaceutical, prostate cancer
Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …
Media reports over Parkinson’s drug risk hit Acadia hard
April 10, 2018Manufacturing and Production, Medical Communications Acadia Pharmaceutical, biotech, drugs, pharma, pharmaceutical
Shortly after the Institute for Safe Medication Practices released a report revealing the number of deaths of patients in those …
Immunomedics’ whirlwind in the C-suite continues
April 10, 2018Manufacturing and Production, Medical Communications AstraZeneca, Immunomedics, Seattle Genetics, biotech, drugs, pharma, pharmaceutical
Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
Latest content
